" class="no-js "lang="en-US"> Anivive Wins Best Animal Health Company by S&P Global's Head of Animal Health - Medtech Alert
Saturday, February 04, 2023

Anivive Wins Best Animal Health Company by S&P Global’s Head of Animal Health

Anivive has been named Best Animal Health Company of 2022 by S&P Global‘s Head of Animal Health for its annual North America award.  Animal Health Connect by S&P Global, the most widely read publication reporting on the animal health industry, announced the award winners on December 19, 2022.

As a startup, Anivive is honored to receive the industry’s top award typically reserved for established industry players and join a list of past recipients that include Zoetis, Merck, and IDEXX. CEO and Co-Founder of Anivive, Dylan Balsz, said, “We are thrilled to receive this award and thankful to the panel of judges for recognizing our team’s hard work and dedication. We have always had a heads down approach to R&D and see this as testament to the belief that hard work speaks for itself.”

S&P Global’s Head of Animal Health, Joseph Harvey stated, “Although [Anivive] didn’t nominate itself for this category, the judges thought this award suited the business” and that Anivive showed the most significant growth and innovation in 2022. Mr.  Harvey also cited Anivive’s discovery software, clinical trial platform, and ability to successfully develop and monetize products across an array of unmet needs as reasons for the award.

This award recognizes Anivive’s commitment to extending the lives of pets by developing software and cutting-edge therapeutics for an affordable price. Anivive remains on track to become profitable in 2022. The Animal Health Awards are granted by a panel of industry expert judges to honor the achievements of companies who have had an outsized impact on the industry over the last 12 months.

  1. Treadwell Therapeutics Announces the Appointment of Roger Sidhu, M.D., as Chief Medical Officer Read more
  2. Personalis and Moderna Sign New Agreement to Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical Trials Read more
  3. Trelleborg to Expand its BioPharmaceutical Manufacturing Footprint in Europe Read more
  4. Revive Therapeutics Enters into Research Collaboration Agreement with PharmaTher for Development of MDMA Transdermal Patch Read more
  5. Accenture Expands Strategy Capabilities in Life Sciences with the Acquisition of Bionest Read more